CHATSWORTH, Calif., April 3, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), this week proudly celebrates 30 years of excellence as a leading in vitro diagnostics company, having evolved from its founding in 1979 as a fledgling research and development stage company with no revenue, to a company today approaching $100 million in sales and more than 300 employees serving the needs of urinalysis across the globe, delivering iQ brand recognized system automation and improving efficiency and quality at laboratories in more than 60 countries, Cesar Garcia, Chairman, President and Chief Executive Officer, announced today.
